HomeEQL • STO
add
EQL Pharma AB
Previous close
kr 83.00
Day range
kr 80.80 - kr 83.10
Year range
kr 48.50 - kr 90.60
Market cap
2.35B SEK
Avg Volume
16.40K
P/E ratio
56.04
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 113.26M | 44.95% |
Operating expense | 23.54M | 1.98% |
Net income | 13.09M | 178.88% |
Net profit margin | 11.56 | 92.35% |
Earnings per share | 0.44 | 175.00% |
EBITDA | 25.67M | 151.27% |
Effective tax rate | 20.78% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 82.40M | 302.58% |
Total assets | 808.82M | 116.40% |
Total liabilities | 587.79M | 199.84% |
Total equity | 221.03M | — |
Shares outstanding | 29.06M | — |
Price to book | 10.91 | — |
Return on assets | 9.05% | — |
Return on capital | 11.07% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 13.09M | 178.88% |
Cash from operations | -13.93M | -378.33% |
Cash from investing | -214.54M | -2,256.27% |
Cash from financing | 295.31M | 1,237.94% |
Net change in cash | 66.84M | 564.78% |
Free cash flow | -226.05M | -2,509.62% |
About
Founded
2006
Website
Employees
21
